Pharma

USFDA nod to Aurobindo Pharma for manufacturing HIV drug

Views: 1.3K

Hyderabad-based pharmaceutical major Aurobindo Pharma has received final approval from the US Food and Drug Administration (USFDA) to make abacavir sulfate and lamivudine tablets, which are used in the treatment of HIV.

“The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture abacavir sulfate and lamivudine tablets, 600 mg/ 300 mg,” the company said in a BSE filing.

The product, with an estimated market size of $388 million, will be launched immediately, according to the Indian pharma major.

With this, Aurobindo Pharma now has a total of 314 ANDA approvals from the US drug regulator.

Most Popular

 

 


 

 

Get Heard Portal

 

eHealth Event Report

 

 

 

About Us

eHEALTH, as an online and print platform, elegantly guides the healthcare stakeholders through the trajectory of healthcare that witnesses fascinating changes on a daily basis due to increased technological intervention and other structural changes to create a ‘community of practice’ of healthcare stakeholders.

email: info@elets.in

Contact Us

Elets Technomedia Pvt. Ltd.
Stellar IT Park, Office No. 7A/7B, 5th Floor, Tower -2 Annexe Building, C-25, Sector 62 Noida, Uttar Pradesh - 201309, India

Copyright © 2018 Elets | All rights reserved

To Top